---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-21-018609"
form_type: "8-K"
ticker: "TECH"
cik: "0000842023"
company_name: "BIO-TECHNE Corp"
filed_at: "2021-08-05T23:59:59+00:00"
generated_at: "2026-06-29T22:08:25.240712+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bio-Techne Q4 FY2021 revenue up 47% to $259M; adjusted EPS $1.87 vs $1.00 YoY

## Summary
- Q4 organic revenue rose 39% to $259.0M; GAAP EPS $0.37, adjusted EPS $1.87 (vs $1.00 prior year).
- Full-year revenue $931.0M, adjusted EPS $6.75, record operating cash flow $352M.
- Protein Sciences organic +46%, Diagnostics & Genomics +22%; adj. operating margin 38.5% vs 31.1%.
- Board declares $0.32/share quarterly dividend, payable Aug 27, 2021 to holders of record Aug 16, 2021.

## SEC filing metadata
- accession: 0001437749-21-018609
- form_type: 8-K
- ticker: TECH
- cik: 0000842023
- company_name: BIO-TECHNE Corp
- filed_at: 2021-08-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/842023/000143774921018609/0001437749-21-018609-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/842023/000143774921018609/tech20210804_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-21-018609
- JSON: https://secwatch.observer/filing/0001437749-21-018609.json
- Plain text: https://secwatch.observer/filing/0001437749-21-018609.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.